Unilateral and bilateral MRI-targeted repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled study.
作者： Daniel M. Blumberger , Jerome J. Maller , Lauren Thomson , Benoit H. Mulsant , Tarek K. Rajji
DOI: 10.1503/JPN.150265
关键词:
摘要: Background Several factors may mitigate the efficacy of repetitive transcranial magnetic stimulation (rTMS) over sham rTMS in patients with treatment-resistant depression (TRD). These include unilateral (i.e., treatment only left dorsolateral prefrontal cortex [DLPFC]), suboptimal methods targeting DLPFC and insufficient intensity (based on coil-to-cortex distance).
sci-hub.se 参考文章(49)
Z Jeff Daskalakis, Andrea J Levinson, Paul B Fitzgerald, Repetitive transcranial magnetic stimulation for major depressive disorder: a review. The Canadian Journal of Psychiatry. ,vol. 53, pp. 555- 566 ,(2008) , 10.1177/070674370805300902
Harold A. Sackeim, The definition and meaning of treatment-resistant depression. The Journal of Clinical Psychiatry. ,vol. 62, pp. 10- 17 ,(2001)
Alison Little, Treatment-resistant depression. American Family Physician. ,vol. 80, pp. 167- 172 ,(2009)
Thomas E. Schlaepfer, Urs P. Mosimann, Hans U. Fisch, Wolfgang Schmitt, Christian W. Hess, Susanne C. Marré, Stefan Werlen, Antidepressant effects of repetitive transcranial magnetic stimulation in the elderly: correlation between effect size and coil-cortex distance. Archives of General Psychiatry. ,vol. 59, pp. 560- 561 ,(2002) , 10.7892/BORIS.43042
William M. Stern, Jose Maria Tormos, Daniel Z. Press, C. Pearlman, Alvaro Pascual-Leone, Antidepressant effects of high and low frequency repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex: a double-blind, randomized, placebo-controlled trial. Journal of Neuropsychiatry and Clinical Neurosciences. ,vol. 19, pp. 179- 186 ,(2007) , 10.1176/JNP.2007.19.2.179
John F Greden, The burden of recurrent depression: causes, consequences, and future prospects. The Journal of Clinical Psychiatry. ,vol. 62, pp. 5- 9 ,(2001)
Amy R. Pettit, Harold Alan Pincus, The societal costs of chronic major depression. The Journal of Clinical Psychiatry. ,vol. 62, pp. 5- 9 ,(2001)
William K. Silverstein, Yoshihiro Noda, Mera S. Barr, Fidel Vila-Rodriguez, Tarek K. Rajji, Paul B. Fitzgerald, Jonathan Downar, Benoit H. Mulsant, Simone Vigod, Zafiris J. Daskalakis, Daniel M. Blumberger, NEUROBIOLOGICAL PREDICTORS OF RESPONSE TO DORSOLATERAL PREFRONTAL CORTEX REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION IN DEPRESSION: A SYSTEMATIC REVIEW Depression and Anxiety. ,vol. 32, pp. 871- 891 ,(2015) , 10.1002/DA.22424
David Rossini, Alessandro Serretti, Linda Franchini, Laura Mandelli, Enrico Smeraldi, Diana De Ronchi, Raffaella Zanardi, Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial. Journal of Clinical Psychopharmacology. ,vol. 25, pp. 471- 475 ,(2005) , 10.1097/01.JCP.0000177548.28961.E7
Sarah H Lisanby, David Gutman, Bruce Luber, Charles Schroeder, Harold A Sackeim, Sham TMS: intracerebral measurement of the induced electrical field and the induction of motor-evoked potentials Biological Psychiatry. ,vol. 49, pp. 460- 463 ,(2001) , 10.1016/S0006-3223(00)01110-0